Oncology Intelligence: Thoracic & Head and Neck

A weekly two-host audio briefing on thoracic and head and neck oncology: the week’s key papers and what oncologists are discussing online. AI-voiced; stories selected and edited by Dr. Rafael Santana-Davila. Views are the editor’s own and do not represent his employers. For healthcare professionals; not medical advice. Latest digest: oncdigest.com/lung/latest — Subscribe: oncdigest.com/subscribe

Folgen

Nur ungehörte

vor 5 Tagen

Week of Nov 2

This week: Dalmelitinib Plus Aumolertinib in Advanced NSCLC Patients With EGFR-TKI Resistance and MET Amplification: A Randomized Phase 3 Trial.; Ruzaltatug rezetecan versus chemotherapy for EGFR-mutated advanced non-small-cell lung cancer

26. Okt.

Week of Oct 26

This week: DeLLphi-305: tarlatamab added to durvalumab maintenance nearly doubles overall survival in extensive-stage SCLC, and the fight shifts to access and sequencing; FLAURA2 ctDNA analysis and PACE-LUNG: early EGFR clearance is prognos

25. Okt.

Introduction: From Powder Reports to PubMed

Start here: what this show is, where it came from, and how papers and posts become each week's episode. Curated by Rafael Santana-Davila, MD, a thoracic oncologist in Seattle, who picks the stories and reviews every script. For healthcare p